COVID-19 and Cardiovascular Disease-Reference-Cited by-同舟云学术

COVID-19 and Cardiovascular Disease

Published:2021-04-16 Issue:8 Volume:128 Page:1214-1236
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circ Res

Author:

Chung Mina K.¹²³^ORCID,Zidar David A.³⁴,Bristow Michael R.⁵^ORCID,Cameron Scott J.¹²³^ORCID,Chan Timothy¹²³,Harding Clifford V.³^ORCID,Kwon Deborah H.¹²³,Singh Tamanna¹²³,Tilton John C.³,Tsai Emily J.⁶,Tucker Nathan R.⁷⁸^ORCID,Barnard John¹²^ORCID,Loscalzo Joseph⁹^ORCID

Affiliation:

1. Cleveland Clinic (M.K.C., S.J.C., T.C., D.H.K., T.S., J.B.), OH.

2. Cleveland Clinic Lerner College of Medicine (M.K.C., S.J.C., T.C., D.H.K., T.S., J.B.), OH.

3. Case Western Reserve University School of Medicine (M.K.C., D.A.Z., S.J.C., T.C., C.V.H., D.H.K., T.S., J.C.T.), OH.

4. Louis Stokes Cleveland Veterans Affairs Medical Center, OH (D.A.Z.).

5. University of Colorado Anschutz Medical Center, Aurora (M.R.B.).

6. Columbia University Vagelos College of Physicians and Surgeons, New York (E.J.T.).

7. Masonic Medical Research Institute, Utica, NY (N.R.T.).

8. Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Boston, MA (N.R.T.).

9. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (J.L.).

Abstract

A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential consequences on the cardiovascular health of millions of people who survive infection worldwide. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the etiologic agent of COVID-19, can infect the heart, vascular tissues, and circulating cells through ACE2 (angiotensin-converting enzyme 2), the host cell receptor for the viral spike protein. Acute cardiac injury is a common extrapulmonary manifestation of COVID-19 with potential chronic consequences. This update provides a review of the clinical manifestations of cardiovascular involvement, potential direct SARS-CoV-2 and indirect immune response mechanisms impacting the cardiovascular system, and implications for the management of patients after recovery from acute COVID-19 infection.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference212 articles.

1. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

2. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19

3. Characterization of Myocardial Injury in Patients With COVID-19

4. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

5. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity;Pharmaceuticals;2024-01-17

2. Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19;Microbiology Spectrum;2024-01-11

3. Younger age is associated with cardiovascular pathological phenotype of severe COVID-19 at autopsy;Frontiers in Medicine;2024-01-08

4. COVID-19 and the risk of acute cardiovascular diseases: A two-sample Mendelian randomization study;2024-01-03

5. The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches;aging and disease;2024